CDT benefits from a higher valuation of its stake in Sarborg as SarborgQ advances quantum-enabled analytics within Signature Intelligence. The move signals external confidence and potential upside if quantum capabilities broaden the platform’s reach. Despite the enthusiasm, CDT trades near its 52-week low, indicating continued volatility and sensitivity to funding and partnership news.
CDT Equity shares rose by 14.71% despite an expected widening net loss of $39.1 million in 2025. Traders are showing interest after recent losses, but upcoming earnings on April 24 could drive volatility in the stock's direction.
